Lawrence Livermore National Laboratory (LLNL) is fully committed to helping protect the U.S. from COVID-19 and to speed the recovery of those affected. As a world-class research institute, we have considerable infrastructure, unique research capabilities and a dedicated team of scientists and engineers supporting the fight against the COVID-19 pandemic.
Because of the California shelter-in-place order, LLNL is currently operating at normal operations with maximized telework; however, our researchers continue to be focused on defeating COVID-19 and are active both on- and off-site.
Since the emergence of the pandemic in January, we have been supporting the research and medical communities with tools and information to better understand COVID-19. For example, on Feb. 3, we released predicted structures of a key COVID-19 viral protein to help the research community accelerate development of potential medical treatments. A summary of our initial research efforts is also available, as is information about our participation in the COVID-19 High Performance Computing Consortium. LLNL is also a part of the Department of Energy’s collective response to the pandemic.
This video summarizes some of the work that Lawrence Livermore researchers and staff are doing to respond to the COVID-19 epidemic.
The Laboratory is a highly collaborative organization, and we welcome partnerships with academia and industry. Our current COVID-19 research and response activities are focused on four broad areas: High Performance Computing, Detection, Medical Countermeasures and Medical Equipment. The Laboratory is also leveraging our unique capabilities and infrastructure to support the fight against COVID-19, as well as creating a COVID-19 data portal to expedite access to our modeling results. Our Innovation and Partnerships Office has identified technologies and capabilities that are currently available under free, temporary non-exclusive licenses. For technical inquiries and collaborative opportunities, please contact the Laboratory’s Biosecurity Center at biosecurity [at] llnl.gov. More information about our current activities can be found on the following pages.
- Accelerated publication - Quantitative form and fit of N95 filtering facepiece respirators are retained and coronavirus surrogate is inactivated after heat treatments
- Accelerated publication - Rapid in silico design of antibodies targeting SARS-CoV-2 using machine learning and supercomputing
- June 25, 2020 - Lab technologies help fight COVID-19
- June 9, 2020 - Lab, BMI produce FDA-approved emergency ventilator
- June 8, 2020 - Multi-lab research to improve COVID-19 diagnostics
- May 29, 2020 - Lab team studies calibrated AI and deep learning models to more reliably diagnose and treat disease
- May 21, 2020 - Lab provides assistance in national swab shortage
- May 19, 2020 - COVID-19 research goes public through new portal
- May 14, 2020 - Deactivating coronavirus on N95 respirators for reuse
- May 1, 2020 - LLNL’s new machine learning platform generates novel COVID-19 antibody sequences for experimental testing
- April 29, 2020 - LLNL develops ‘stopgap’ ventilator for COVID-19 use
- April 21, 2020 - Upgrades for LLNL supercomputer from AMD, Penguin Computing aid COVID-19 research
- March 26, 2020 - New partnership to unleash U.S. supercomputing resources in the fight against COVID-19
- March 26, 2020 - Lab antibody, anti-viral research aids COVID-19 response
- February 3, 2020 - Lawrence Livermore researchers release 3D protein structure predictions for the novel coronavirus
- May 5, 2020 - Advanced manufacturing innovation helps industry in COVID-19 fight
- May 5, 2020 - 3-D printed COVID-19 test swabs pass their own tests
- May 4, 2020 - Swab Shortage: FATHOM & Abiogenix Bridge the Gap with 3D Printed NP Swabs
- April 14, 2020 - LLNL’s Jim Brase explains how DOE labs are fighting (and coping with) COVID-19
- February 5, 2020 - Coronavirus: Lawrence Livermore Lab researchers examine virus in hopes of blocking, treating it
For more information about the U.S. government's response to COVID-19, see coronavirus.gov and usa.gov/coronavirus. For the latest public health and safety information from the Centers for Disease Control and Prevention, see cdc.gov/coronavirus.